Literature DB >> 17332981

Nodular pulmonary amyloidosis in a patient with rheumatoid arthritis.

J Calatayud1, G Candelas, A Gómez, C Morado, F Hernando Trancho.   

Abstract

We describe a 67-year-old white woman with a long-standing active rheumatoid arthritis who refused treatment. Chest roentgenograms performed in 2000 revealed a pulmonary nodule in the mid-left lung. Progression of the nodule was followed annually by computerized tomography (CT). In the last CT in 2002, we observed multiple nodules in both lungs in the absence of lymph gland involvement. The patient was operated by video-thoracoscopy to resect one of the pulmonary nodules. Pathological examination of the excised tissue revealed amyloid A-type (AA) amyloidosis. Although pulmonary amyloidosis is rare in patients with systemic AA amyloidosis, we recommend that this possibility be considered when confronted with a patient with these characteristics.

Entities:  

Mesh:

Year:  2007        PMID: 17332981     DOI: 10.1007/s10067-007-0552-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  8 in total

Review 1.  Amyloidosis and the respiratory tract.

Authors:  J D Gillmore; P N Hawkins
Journal:  Thorax       Date:  1999-05       Impact factor: 9.139

2.  The radiologic spectrum of cardiopulmonary amyloidosis.

Authors:  E Himmelfarb; S Wells; J G Rabinowitz
Journal:  Chest       Date:  1977-09       Impact factor: 9.410

3.  Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients.

Authors:  R L Comenzo; E Vosburgh; R H Falk; V Sanchorawala; J Reisinger; S Dubrey; L M Dember; J L Berk; G Akpek; M LaValley; C O'hara; C F Arkin; D G Wright; M Skinner
Journal:  Blood       Date:  1998-05-15       Impact factor: 22.113

4.  CT appearance of localized pulmonary amyloidosis.

Authors:  M C Ayuso; R Gilabert; J A Bombi; A Salvador
Journal:  J Comput Assist Tomogr       Date:  1987 Jan-Feb       Impact factor: 1.826

5.  Pulmonary amyloidosis. The Mayo Clinic experience from 1980 to 1993.

Authors:  J P Utz; S J Swensen; M A Gertz
Journal:  Ann Intern Med       Date:  1996-02-15       Impact factor: 25.391

6.  Allogeneic bone marrow transplantation for systemic AL amyloidosis.

Authors:  J D Gillmore; J Davies; A Iqbal; S Madhoo; N H Russell; P N Hawkins
Journal:  Br J Haematol       Date:  1998-01       Impact factor: 6.998

7.  A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.

Authors:  R A Kyle; M A Gertz; P R Greipp; T E Witzig; J A Lust; M Q Lacy; T M Therneau
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

8.  Amyloidosis of the lower respiratory tract. Clinical and pathologic features in a series of 21 patients.

Authors:  J F Cordier; R Loire; J Brune
Journal:  Chest       Date:  1986-12       Impact factor: 9.410

  8 in total
  1 in total

1.  A Tale of Three Rarities: Secondary Amyloid A (AA) Amyloidosis Caused by Recurrent Sialadenitis and Complicated by Pulmonary Hypertension and Adrenal Insufficiency.

Authors:  Parth Desai; Chimezie Mbachi; Udit Joshi; Benjamin Mba
Journal:  Cureus       Date:  2020-04-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.